Holstein A, Lankes H G, Egberts E H
Medizinische Klinik, Klinikums Lippe-Detmold.
Med Klin (Munich). 1998 Jun 15;93(6):374-7. doi: 10.1007/BF03044682.
The neuroglycopenic syndrome, which is often due to sulfonylurea-induced hypoglycemia, is frequently overlooked or misinterpretated as cerebral ischemia.
Two women aged 81 and 83 years, respectively, with type II diabetes treated with sulfonylureas presented with hemiparesis, dysphasia and somnolence. Both, general practitioner and emergency room physician first interpretated the symptoms as clinical signs of stroke without determination of blood glucose. After hours of delay due to unnecessary and expensive examinations including cerebral computed tomography the correct diagnosis of hypoglycemia was finally made. After injection of i.v. glucose the symptomatology was completely reversible.
In every case of disturbance of consciousness, acute neurologic deficits and psychiatric abnormalities an immediate blood glucose test should be performed to exclude hypoglycemia.
神经低血糖症候群常由磺脲类药物诱发的低血糖所致,常被忽视或误诊为脑缺血。
两名分别为81岁和83岁的女性,均患II型糖尿病,正在接受磺脲类药物治疗,出现偏瘫、言语困难和嗜睡症状。全科医生和急诊室医生最初均未测定血糖,而是将这些症状误诊为中风的临床体征。在进行了包括脑部计算机断层扫描在内的不必要且昂贵的检查后延误了数小时,最终才正确诊断为低血糖。静脉注射葡萄糖后,症状完全可逆。
对于每一例意识障碍、急性神经功能缺损和精神异常的病例,均应立即进行血糖检测以排除低血糖。